Archimedis Digital has expanded its AI Center of Excellence in Tiruchirappalli to accelerate AI-driven innovation in life sciences and support global digital transformation initiatives.
Glimpse:
Archimedis Digital has scaled its AI Center of Excellence in Tiruchirappalli, focusing on AI, machine learning, and data science solutions for pharma, biotech, and medtech sectors. The expansion also includes plans to double its workforce within a year to meet rising demand.
Archimedis Digital has announced the expansion of its AI Center of Excellence (CoE) in Tiruchirappalli, Tamil Nadu, marking a strategic move to strengthen its artificial intelligence capabilities for the life sciences sector.
The expanded CoE is designed as a dedicated hub for AI, machine learning, and data science innovation. It will support the development of next generation digital platforms and intelligent solutions tailored for pharmaceutical, biotechnology, and medical device companies.
This initiative aligns with the growing global demand for data driven healthcare systems. The center will focus on critical areas such as pharmacovigilance, regulatory compliance, and large scale digital transformation projects domains that require high accuracy and strict adherence to regulatory standards.
As part of its growth strategy, Archimedis Digital plans to double its workforce within the next 12 months, with a significant portion of hiring dedicated to AI, machine learning, and data science roles. This reflects a broader industry shift toward domain specific AI expertise in life sciences.
The company is also adopting a Tier-2 city talent strategy, positioning Tiruchirappalli as a key innovation hub. By tapping into talent beyond major metros and investing in structured training, Archimedis aims to build a sustainable workforce that combines domain knowledge with AI expertise.
Headquartered in Princeton, New York, Archimedis Digital operates with a strong presence in Chennai and a growing team in Tiruchirappalli. The expansion supports a hybrid talent model that bridges the gap between deep life sciences expertise and scalable AI applications.
Industry experts view this move as part of a larger trend where healthcare and life sciences companies are increasingly leveraging AI not just for automation, but for decision support, compliance, and operational efficiency.
Overall, the expansion reinforces Archimedis Digital’s ambition to become a key player in AI-driven digital transformation for the global life sciences ecosystem, while also highlighting the rising importance of Tier-2 cities in India’s technology growth story.
“AI in life sciences is no longer just about automation it’s about enabling smarter, compliant, and data-driven decisions.”
By
HB Team
Related News
